Data as of Jul 31
| 0.00 / 0.00%|
The 14 analysts offering 12-month price forecasts for CSPC Pharmaceutical Group Ltd have a median target of 46.28, with a high estimate of 58.70 and a low estimate of 40.96. The median estimate represents a +14.84% increase from the last price of 40.30.
The current consensus among 14 polled investment analysts is to Buy stock in CSPC Pharmaceutical Group Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.